{"gene":"CRYAA","run_date":"2026-06-09T22:57:19","timeline":{"discoveries":[{"year":1998,"finding":"A missense mutation R116C in CRYAA (alphaA-crystallin) is associated with autosomal dominant congenital cataract, establishing CRYAA as a causative gene for hereditary lens opacity.","method":"Linkage analysis and gene sequencing in an ADCC family","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic mapping plus sequencing, replicated across multiple subsequent families, but no in vitro functional assay in this paper","pmids":["9467006"],"is_preprint":false},{"year":2008,"finding":"The R116H mutation in alphaA-crystallin increases hydrophobicity of the protein, abolishes chaperone activity in a DTT-induced insulin aggregation assay, and increases binding affinity to lysozyme, indicating loss of normal chaperone function as the molecular basis for cataract formation.","method":"Recombinant protein expression in E. coli, RP-HPLC (hydrophobicity), FPLC (binding affinity), in vitro chaperone activity assay (insulin aggregation)","journal":"Human mutation","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal in vitro assays (chaperone activity, hydrophobicity, binding affinity) in a single rigorous study on purified recombinant protein","pmids":["18407550"],"is_preprint":false},{"year":2012,"finding":"CRYAA released from injured keratocytes acts as a DAMP and activates resident macrophages via the TLR2/NF-κB signaling pathway, triggering Phase II sterile corneal inflammation responsible for vision-threatening opacity. This was suppressed in HSPB4-knockout or TLR2-knockout mice, and by anti-HSPB4 antibodies.","method":"Mouse knockout models (HSPB4-/-, TLR2-/-), antibody inhibition, temporal kinetic analysis of neutrophil infiltration, NF-κB pathway analysis","journal":"EMBO molecular medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal genetic and pharmacological approaches (two KO lines, antibody blockade, pathway analysis) in a single study, clearly establishing mechanism","pmids":["22359280"],"is_preprint":false},{"year":2012,"finding":"CRYAA expression is epigenetically repressed in age-related nuclear cataract lens epithelia via CpG island hypermethylation of the CRYAA promoter; treatment with the demethylating agent zebularine restores CRYAA mRNA and protein expression.","method":"Bisulfite genomic sequencing, RT-PCR, Western blot, demethylating agent treatment (zebularine)","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — bisulfite sequencing plus functional rescue with demethylating agent, single lab but two orthogonal methods","pmids":["22889833"],"is_preprint":false},{"year":2016,"finding":"Methylation of CpG sites in the CRYAA promoter directly reduces binding of transcription factor Sp1, providing the mechanistic link between promoter hypermethylation and transcriptional silencing of CRYAA.","method":"Electrophoretic mobility shift assay (EMSA) with methylated vs. unmethylated probes, demethylating agent treatment with qRT-PCR","journal":"BMC ophthalmology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA directly demonstrates reduced Sp1 binding upon methylation, supported by functional restoration data, single lab","pmids":["27507241"],"is_preprint":false},{"year":2011,"finding":"HspB4 (CRYAA) forms hetero-complexes with HspB5 (alphaB-crystallin), and subunit exchange kinetics between HspB4 and HspB5 are slower than between HspB1 and HspB5. HspB4-HspB5 hetero-complexes exhibit distinct chaperone-like activity and structural properties compared to either homo-oligomer, suggesting that hetero-complex formation expands functional range.","method":"Biochemical and biophysical characterization (size exclusion chromatography, small-angle X-ray scattering), subunit exchange kinetics, in vitro chaperone activity assays","journal":"Biochimie","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — multiple biophysical and biochemical methods in vitro, single lab","pmids":["22210387"],"is_preprint":false},{"year":2018,"finding":"Substitution of the conserved Arg in the N-terminal RLFDQxFG motif of HspB4 (R12 equivalent region) induces only minor changes in thermal stability and oligomeric structure compared to the larger effects seen in HspB1 and HspB8, indicating that this motif plays a distinct, context-dependent structural role in HspB4.","method":"Biophysical characterization (thermal stability, intrinsic fluorescence, size exclusion chromatography) of recombinant Arg-to-Ala mutant proteins","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro mutagenesis with multiple biophysical readouts, single lab","pmids":["30036999"],"is_preprint":false},{"year":2021,"finding":"HspB4/αA-crystallin phosphorylation at T148 regulates its anti-inflammatory function in retinal Müller glial cells: phosphomimetic T148D mutant significantly reduced expression of pro-inflammatory cytokines (IL-6, IL-1β, MCP-1, IL-18), suppressed NLRP3 inflammasome components, and nearly abolished NF-κB induction, whereas non-phosphorylatable T148A mutant was ineffective.","method":"Primary Müller glial cells from HSPB4 knockout mice, transfection with WT/T148D/T148A plasmids, qPCR for inflammatory markers, Western blot for NF-κB and NLRP3 subcellular localization","journal":"Journal of clinical medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phosphorylation-specific mutants in primary cells with multiple inflammatory readouts, single lab","pmids":["34071438"],"is_preprint":false},{"year":2024,"finding":"αA-crystallin (HSPB4) interacts with the neuroprotective protein FAIM2, and this interaction requires phosphorylation of αA-crystallin at T148. During retinal detachment, FAIM2 is induced and co-immunoprecipitates with αA-crystallin, and αA-crystallin stabilizes FAIM2 to promote photoreceptor survival.","method":"Co-immunoprecipitation, immunohistochemistry, immunoblotting, TUNEL staining, cell culture model with FasL-induced photoreceptor death, phosphomimetic/non-phosphorylatable mutants","journal":"Neurology international","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP plus functional cell viability data and in vivo retinal detachment model, single lab","pmids":["39311341"],"is_preprint":false},{"year":2024,"finding":"mTORC2 is identified as a kinase that phosphorylates HSPB4 at T148 in vitro; additionally, the chaperone function of HSPB4 further strengthens the interaction with mTORC2, suggesting a multi-faceted regulatory relationship.","method":"In vitro kinome profiling, bioinformatics analysis, chemoproteomics, in vitro kinase assay","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay plus chemoproteomics for interaction, single lab, T148 phosphorylation confirmed in vitro","pmids":["39682748"],"is_preprint":false},{"year":2018,"finding":"The R12L mutation in CRYAA causes aggregation of the mutant protein in the insoluble fraction, forms large cytoplasmic aggregates and aggresomes in HeLa cells, and increases overall CRYAA protein expression levels, suggesting that mutation-induced aggregation underlies cataract pathogenesis.","method":"Transfection of WT and R12L-CRYAA in HEK293T and HeLa cells, Western blotting (solubility), immunofluorescence (aggresome formation)","journal":"BMC medical genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two orthogonal methods (solubility fractionation and immunofluorescence) in two cell lines, single lab","pmids":["30340470"],"is_preprint":false},{"year":2021,"finding":"In a CRYAA Y118D mutant mouse model, cataract formation is associated with activation of the endoplasmic reticulum stress-unfolded protein response (ERS-UPR) pathway, with up-regulated ERS-UPR genes; prolonged UPR activation leads to proteotoxic cell death in lens fibers.","method":"Knock-in mouse model, histological analysis, transcriptome analysis, key pathway analysis","journal":"Zoological research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo mouse model with transcriptomic pathway analysis, single lab","pmids":["33929105"],"is_preprint":false},{"year":2023,"finding":"Silencing of CRYAA in HLEB3 lens epithelial cells increases apoptosis and autophagy, demonstrating that CRYAA is required to suppress apoptotic and autophagic pathways in lens epithelial cell homeostasis.","method":"siRNA knockdown, Western blotting for apoptosis and autophagy markers, flow cytometry, CCK-8 viability assay","journal":"Aging","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single knockdown approach with limited pathway resolution in abstract","pmids":["37253645"],"is_preprint":false},{"year":2025,"finding":"CRYAA overexpression in RPE cells reduces miR-155-5p levels, which in turn de-represses SIRT1 (confirmed by dual luciferase assay showing miR-155-5p binds SIRT1 3'-UTR), leading to activation of the PI3K/AKT signaling pathway and protection from H2O2-induced apoptosis.","method":"Stable overexpression in ARPE-19 cells, RT-qPCR, dual luciferase reporter assay, Western blotting for PI3K/AKT pathway, flow cytometry for apoptosis, in vivo mouse retinal degeneration model with AAV-Cryaa injection","journal":"Archives of biochemistry and biophysics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — luciferase reporter confirms miR-155-5p/SIRT1 binding site, pathway confirmed by SIRT1 silencing rescue experiment and in vivo AAV model, single lab","pmids":["40350053"],"is_preprint":false},{"year":2023,"finding":"The E156K mutation in CRYAA induces epithelial-mesenchymal transition (EMT) in human lens epithelial cells, increasing mesenchymal markers (N-cadherin, vimentin) and decreasing epithelial marker (E-cadherin), with enhanced cell migration via activation of FAK/Src and Wnt/β-catenin signaling pathways.","method":"Knockdown and replacement with WT or E156K-mutant CRYAA in HLECs, Western blotting for EMT markers, rhodamine cytoskeleton staining, migration assay, β-catenin inhibitor (ICG001) and FAK/Src inhibitor treatments","journal":"Heliyon","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (morphology, protein markers, functional migration assay, pharmacological inhibition), single lab","pmids":["38187316"],"is_preprint":false},{"year":2008,"finding":"A 148 kb BAC transgene containing the Cryaa locus recapitulates endogenous alphaA-crystallin expression pattern in the lens. Deletion of the distal control region DCR3 from either the BAC or a 15 kb Cryaa fragment shows that DCR3 functions as a distal enhancer active during late primary lens fiber cell differentiation.","method":"BAC transgenic mice, standard transgenic mice, EGFP reporter, temporal/spatial expression analysis by fluorescence imaging","journal":"BMC developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — BAC transgenic approach with deletion of regulatory region and comparison to endogenous expression, single lab","pmids":["18803847"],"is_preprint":false},{"year":2023,"finding":"HSPB4 (CRYAA) activates TLR2 signaling in corneal cells acting as a DAMP; dioleoylphosphatidylglycerol (DOPG) inhibits TLR2 activation induced by HSPB4 in vitro, and this TLR2 activation requires the co-receptor CD14.","method":"In vitro TLR2 activation assay, CD14 co-receptor requirement established by knockdown/inhibition","journal":"International journal of molecular sciences","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single in vitro assay, single lab, CD14 requirement inferred from inhibition experiments described briefly in abstract","pmids":["36982926"],"is_preprint":false}],"current_model":"CRYAA (alphaA-crystallin/HspB4) functions as a lens-predominant molecular chaperone that prevents aggregation of β/γ-crystallins to maintain lens transparency; disease-causing mutations (e.g., R116C/H, R12C/L, R54C) reduce chaperone activity, increase hydrophobicity, and/or promote protein aggregation/aggresome formation, causing congenital cataract; outside the lens, CRYAA acts as a DAMP released from injured cells to activate macrophages via a TLR2/NF-κB axis driving sterile corneal inflammation, and in retinal cells its phosphorylation at T148 by mTORC2 regulates anti-inflammatory (NLRP3/NF-κB suppression), anti-apoptotic, and neuroprotective functions including stabilization of FAIM2; CRYAA transcription is regulated by Sp1 binding to its promoter, which is silenced by CpG methylation in age-related cataract."},"narrative":{"mechanistic_narrative":"CRYAA (alphaA-crystallin/HspB4) is a lens-predominant small heat-shock protein whose core function is molecular chaperone activity that prevents protein aggregation to maintain lens transparency, with additional context-dependent cytoprotective and immunomodulatory roles in cornea and retina [PMID:18407550, PMID:22359280]. Within the lens it suppresses substrate aggregation, and the disease-causing R116H substitution increases protein hydrophobicity, raises lysozyme-binding affinity, and abolishes chaperone activity, defining loss of chaperone function as one molecular route to cataract [PMID:18407550]. CRYAA participates in mixed oligomers, forming hetero-complexes with HspB5/alphaB-crystallin that display distinct chaperone-like activity and slower subunit exchange than other small-HSP pairs [PMID:22210387]. Multiple dominant cataract mutations act through gain-of-toxicity mechanisms rather than simple loss of chaperoning: R12L drives accumulation of insoluble protein and cytoplasmic aggresomes [PMID:30340470], Y118D triggers ER-stress/unfolded-protein-response activation and proteotoxic death in lens fibers [PMID:33929105], and E156K induces epithelial-mesenchymal transition in lens epithelial cells via FAK/Src and Wnt/beta-catenin signaling [PMID:38187316]. CRYAA itself is required for lens epithelial homeostasis, restraining apoptosis and autophagy [PMID:37253645], and its expression is silenced in age-related cataract by CpG hypermethylation of its promoter, which reduces Sp1 binding and transcription [PMID:22889833, PMID:27507241]. Outside the lens, CRYAA released from injured keratocytes functions as a DAMP that activates resident macrophages through a TLR2/NF-kappaB axis to drive sterile corneal inflammation [PMID:22359280]. In the retina, mTORC2-mediated phosphorylation of CRYAA at T148 confers anti-inflammatory, anti-apoptotic, and neuroprotective activity, including suppression of NLRP3/NF-kappaB signaling [PMID:34071438, PMID:39682748] and phosphorylation-dependent binding and stabilization of the pro-survival factor FAIM2 to protect photoreceptors [PMID:39311341]. The R116C mutation in CRYAA causes autosomal dominant congenital cataract [PMID:9467006].","teleology":[{"year":1998,"claim":"Established CRYAA as a disease gene by linking a specific missense mutation to inherited lens opacity, answering whether crystallin genes themselves cause cataract.","evidence":"Linkage analysis and gene sequencing in an autosomal dominant congenital cataract family","pmids":["9467006"],"confidence":"Medium","gaps":["No in vitro functional assay to show how R116C alters protein behavior","Did not distinguish loss-of-function from gain-of-toxicity"]},{"year":2008,"claim":"Resolved the molecular basis of mutation-driven cataract by showing the disease substitution abolishes chaperone activity and increases hydrophobicity, defining a loss-of-chaperone mechanism.","evidence":"Recombinant R116H protein with RP-HPLC, FPLC binding, and insulin-aggregation chaperone assays","pmids":["18407550"],"confidence":"High","gaps":["In vitro assays do not establish in vivo lens consequences","Tested R116H rather than the original R116C allele"]},{"year":2008,"claim":"Identified the genomic regulatory element controlling lens-specific CRYAA expression, addressing how the gene is restricted to differentiating fiber cells.","evidence":"BAC transgenic mice with EGFP reporter and deletion of the DCR3 distal enhancer","pmids":["18803847"],"confidence":"Medium","gaps":["Trans-acting factors binding DCR3 not identified","Single transgenic system"]},{"year":2011,"claim":"Defined CRYAA's oligomeric biology by showing it forms hetero-complexes with HspB5 with distinct properties, refining what the functional chaperone species actually is.","evidence":"SEC, SAXS, subunit-exchange kinetics, and in vitro chaperone assays of HspB4/HspB5 complexes","pmids":["22210387"],"confidence":"Medium","gaps":["In vivo relevance of hetero-complex stoichiometry not established","Single lab biophysical study"]},{"year":2012,"claim":"Revealed an unexpected extracellular, pro-inflammatory role by showing released CRYAA acts as a DAMP driving sterile corneal inflammation through TLR2/NF-kappaB.","evidence":"HSPB4-/- and TLR2-/- mice, anti-HSPB4 antibody blockade, and NF-kappaB pathway analysis","pmids":["22359280"],"confidence":"High","gaps":["Direct CRYAA-TLR2 binding not structurally defined","Receptor co-factors not yet mapped"]},{"year":2012,"claim":"Explained age-related loss of CRYAA expression by demonstrating promoter CpG hypermethylation represses transcription and is reversible by demethylation.","evidence":"Bisulfite sequencing, RT-PCR, Western blot, and zebularine rescue in cataract lens epithelia","pmids":["22889833"],"confidence":"Medium","gaps":["Did not identify the transcription factor affected by methylation","Correlative human-tissue data"]},{"year":2016,"claim":"Provided the mechanistic link for methylation-driven silencing by showing methylated CpG sites reduce Sp1 binding to the CRYAA promoter.","evidence":"EMSA with methylated vs unmethylated probes plus demethylation/qRT-PCR","pmids":["27507241"],"confidence":"Medium","gaps":["Other transcription factors at the promoter not excluded","Single-lab EMSA evidence"]},{"year":2018,"claim":"Showed that not all cataract mutations act by loss of chaperoning, identifying R12L as a gain-of-toxicity allele that drives insoluble aggregation and aggresome formation.","evidence":"Transfection of WT/R12L in HEK293T and HeLa cells with solubility fractionation and immunofluorescence","pmids":["30340470"],"confidence":"Medium","gaps":["Aggregation shown in non-lens cell lines","Chaperone activity of R12L not directly measured"]},{"year":2018,"claim":"Tested the structural role of the conserved N-terminal Arg motif, showing CRYAA differs from other small HSPs and that this residue has a context-dependent role.","evidence":"Biophysical characterization of Arg-to-Ala mutants (thermal stability, fluorescence, SEC)","pmids":["30036999"],"confidence":"Medium","gaps":["Did not connect motif perturbation to disease phenotype","Single-lab biophysics"]},{"year":2021,"claim":"Established a phosphorylation switch by showing T148 phosphorylation governs CRYAA's anti-inflammatory activity in retinal Muller glia.","evidence":"Phosphomimetic T148D vs T148A in primary HSPB4-knockout Muller cells with inflammatory marker qPCR and NF-kappaB/NLRP3 readouts","pmids":["34071438"],"confidence":"Medium","gaps":["The responsible kinase was not yet identified","Single cell-type model"]},{"year":2021,"claim":"Connected a cataract mutation to a proteostasis stress pathway in vivo, showing Y118D activates ER-stress/UPR leading to proteotoxic fiber cell death.","evidence":"Y118D knock-in mouse with histology and transcriptome pathway analysis","pmids":["33929105"],"confidence":"Medium","gaps":["Causal versus consequential role of UPR not separated","Single mutant allele studied"]},{"year":2023,"claim":"Demonstrated CRYAA is required for lens epithelial homeostasis by showing its loss elevates apoptosis and autophagy.","evidence":"siRNA knockdown in HLEB3 cells with apoptosis/autophagy markers, flow cytometry, and viability assay","pmids":["37253645"],"confidence":"Low","gaps":["Single knockdown approach with limited pathway resolution","No rescue control reported","Mechanism linking CRYAA to autophagy unresolved"]},{"year":2023,"claim":"Identified a non-chaperone disease mechanism by which the E156K mutation drives EMT in lens epithelium through FAK/Src and Wnt/beta-catenin signaling.","evidence":"Knockdown-replacement of WT vs E156K in HLECs with EMT markers, migration assays, and pathway inhibitors","pmids":["38187316"],"confidence":"Medium","gaps":["How E156K engages FAK/Src or Wnt is not defined","Single-lab cell model"]},{"year":2023,"claim":"Refined the corneal DAMP mechanism by establishing CD14 as a required co-receptor for CRYAA-driven TLR2 activation and identifying DOPG as an inhibitor.","evidence":"In vitro TLR2 activation assay with CD14 knockdown/inhibition and DOPG treatment","pmids":["36982926"],"confidence":"Low","gaps":["Single in vitro assay with CD14 requirement inferred from inhibition","Not confirmed in vivo"]},{"year":2024,"claim":"Identified the kinase for the T148 phosphoswitch, showing mTORC2 phosphorylates CRYAA in vitro and that chaperone function reinforces the interaction.","evidence":"In vitro kinome profiling, chemoproteomics, and in vitro kinase assay","pmids":["39682748"],"confidence":"Medium","gaps":["T148 phosphorylation by mTORC2 confirmed only in vitro","Cellular and in vivo regulation not yet validated"]},{"year":2024,"claim":"Linked the T148 phosphoswitch to a concrete neuroprotective output by showing phospho-dependent binding and stabilization of FAIM2 to promote photoreceptor survival.","evidence":"Reciprocal Co-IP, retinal detachment model, TUNEL, and phosphomimetic mutants in FasL-induced photoreceptor death","pmids":["39311341"],"confidence":"Medium","gaps":["Mechanism by which CRYAA stabilizes FAIM2 not resolved","Single-lab model"]},{"year":2025,"claim":"Defined a cytoprotective signaling axis in retinal pigment epithelium whereby CRYAA lowers miR-155-5p to de-repress SIRT1 and activate PI3K/AKT against oxidative apoptosis.","evidence":"ARPE-19 overexpression, dual-luciferase miR-155-5p/SIRT1 binding, pathway Western blots, SIRT1-silencing rescue, and AAV-Cryaa in vivo model","pmids":["40350053"],"confidence":"Medium","gaps":["How CRYAA regulates miR-155-5p levels is unknown","Single-lab study"]},{"year":null,"claim":"How CRYAA's intracellular chaperone activity, its phosphorylation-dependent signaling roles, and its extracellular DAMP function are integrated within a single tissue context remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of how T148 phosphorylation alters oligomer or partner binding","Relationship between hetero-complex composition and tissue-specific function unclear","Whether non-chaperone disease mechanisms (aggregation, EMT, UPR) share a common upstream trigger is unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[1,5]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[8]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[10]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[2]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[1,5]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[2,7]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[12,13]}],"complexes":["HspB4-HspB5 (alphaA/alphaB-crystallin) hetero-oligomer"],"partners":["CRYAB","TLR2","CD14","FAIM2","MTORC2","SP1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P02489","full_name":"Alpha-crystallin A chain","aliases":["Heat shock protein beta-4","HspB4","Heat shock protein family B member 4"],"length_aa":173,"mass_kda":19.9,"function":"Contributes to the transparency and refractive index of the lens (PubMed:18302245). In its oxidized form (absence of intramolecular disulfide bond), acts as a chaperone, preventing aggregation of various proteins under a wide range of stress conditions (PubMed:18199971, PubMed:19595763, PubMed:22120592, PubMed:31792453). Required for the correct formation of lens intermediate filaments as part of a complex composed of BFSP1, BFSP2 and CRYAA (PubMed:28935373)","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/P02489/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CRYAA","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CRYAA","total_profiled":1310},"omim":[{"mim_id":"619187","title":"GALECTIN-RELATED INTERFIBER PROTEIN; GRIFIN","url":"https://www.omim.org/entry/619187"},{"mim_id":"616767","title":"CALPAIN, SMALL SUBUNIT 2; CAPNS2","url":"https://www.omim.org/entry/616767"},{"mim_id":"610019","title":"CATARACT 18; CTRCT18","url":"https://www.omim.org/entry/610019"},{"mim_id":"604624","title":"HEAT-SHOCK 27-KD PROTEIN 3; HSPB3","url":"https://www.omim.org/entry/604624"},{"mim_id":"604219","title":"CATARACT 9, MULTIPLE TYPES; CTRCT9","url":"https://www.omim.org/entry/604219"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"kidney","ntpm":104.3},{"tissue":"retina","ntpm":95.5}],"url":"https://www.proteinatlas.org/search/CRYAA"},"hgnc":{"alias_symbol":["HSPB4"],"prev_symbol":["CRYA1"]},"alphafold":{"accession":"P02489","domains":[{"cath_id":"2.60.40.790","chopping":"20-30_56-146","consensus_level":"medium","plddt":87.6356,"start":20,"end":146}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P02489","model_url":"https://alphafold.ebi.ac.uk/files/AF-P02489-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P02489-F1-predicted_aligned_error_v6.png","plddt_mean":74.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CRYAA","jax_strain_url":"https://www.jax.org/strain/search?query=CRYAA"},"sequence":{"accession":"P02489","fasta_url":"https://rest.uniprot.org/uniprotkb/P02489.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P02489/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P02489"}},"corpus_meta":[{"pmid":"9467006","id":"PMC_9467006","title":"Autosomal dominant congenital cataract associated with a missense mutation in the human alpha crystallin gene CRYAA.","date":"1998","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9467006","citation_count":386,"is_preprint":false},{"pmid":"11006246","id":"PMC_11006246","title":"A nonsense mutation (W9X) in CRYAA causes autosomal recessive cataract in an inbred Jewish Persian family.","date":"2000","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/11006246","citation_count":157,"is_preprint":false},{"pmid":"17724170","id":"PMC_17724170","title":"Genetic heterogeneity in microcornea-cataract: five novel mutations in CRYAA, CRYGD, and GJA8.","date":"2007","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/17724170","citation_count":123,"is_preprint":false},{"pmid":"29959922","id":"PMC_29959922","title":"Circular RNA HIPK3 regulates human lens epithelial cells proliferation and apoptosis by targeting the miR-193a/CRYAA axis.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29959922","citation_count":86,"is_preprint":false},{"pmid":"24514166","id":"PMC_24514166","title":"HspB1, HspB5 and HspB4 in Human Cancers: Potent Oncogenic Role of Some of Their Client Proteins.","date":"2014","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/24514166","citation_count":77,"is_preprint":false},{"pmid":"16862070","id":"PMC_16862070","title":"Identification of a novel, putative cataract-causing allele in CRYAA (G98R) in an Indian family.","date":"2006","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/16862070","citation_count":66,"is_preprint":false},{"pmid":"16453125","id":"PMC_16453125","title":"Congenital cataract and macular hypoplasia in humans associated with a de novo mutation in CRYAA and compound heterozygous mutations in P.","date":"2006","source":"Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie","url":"https://pubmed.ncbi.nlm.nih.gov/16453125","citation_count":63,"is_preprint":false},{"pmid":"22889833","id":"PMC_22889833","title":"Down-regulation and CpG island hypermethylation of CRYAA in age-related nuclear cataract.","date":"2012","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/22889833","citation_count":62,"is_preprint":false},{"pmid":"17937925","id":"PMC_17937925","title":"Recessive congenital total cataract with microcornea and heterozygote carrier signs caused by a novel missense CRYAA mutation (R54C).","date":"2007","source":"American journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/17937925","citation_count":57,"is_preprint":false},{"pmid":"19390652","id":"PMC_19390652","title":"Mutation analysis of CRYAA, CRYGC, and CRYGD associated with autosomal dominant congenital cataract in Brazilian families.","date":"2009","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/19390652","citation_count":56,"is_preprint":false},{"pmid":"29425965","id":"PMC_29425965","title":"The small heat shock proteins, especially HspB4 and HspB5 are promising protectants in neurodegenerative diseases.","date":"2018","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/29425965","citation_count":52,"is_preprint":false},{"pmid":"22359280","id":"PMC_22359280","title":"Identification of the HSPB4/TLR2/NF-κB axis in macrophage as a therapeutic target for sterile inflammation of the cornea.","date":"2012","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22359280","citation_count":50,"is_preprint":false},{"pmid":"18407550","id":"PMC_18407550","title":"A novel mutation in AlphaA-crystallin (CRYAA) caused autosomal dominant congenital cataract in a large Chinese family.","date":"2008","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/18407550","citation_count":50,"is_preprint":false},{"pmid":"3610158","id":"PMC_3610158","title":"Confirmation of assignment of the human alpha 1-crystallin gene (CRYA1) to chromosome 21 with regional localization to q22.3.","date":"1987","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/3610158","citation_count":48,"is_preprint":false},{"pmid":"16735993","id":"PMC_16735993","title":"A novel fan-shaped cataract-microcornea syndrome caused by a mutation of CRYAA in an Indian family.","date":"2006","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/16735993","citation_count":47,"is_preprint":false},{"pmid":"18302245","id":"PMC_18302245","title":"Clinical variability of autosomal dominant cataract, microcornea and corneal opacity and novel mutation in the alpha A crystallin gene (CRYAA).","date":"2008","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/18302245","citation_count":40,"is_preprint":false},{"pmid":"17296897","id":"PMC_17296897","title":"New phenotype associated with an Arg116Cys mutation in the CRYAA gene: nuclear cataract, iris coloboma, and microphthalmia.","date":"2007","source":"Archives of ophthalmology (Chicago, Ill. : 1960)","url":"https://pubmed.ncbi.nlm.nih.gov/17296897","citation_count":36,"is_preprint":false},{"pmid":"22210387","id":"PMC_22210387","title":"Structural and functional specificity of small heat shock protein HspB1 and HspB4, two cellular partners of HspB5: role of the in vitro hetero-complex formation in chaperone activity.","date":"2011","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/22210387","citation_count":28,"is_preprint":false},{"pmid":"30036999","id":"PMC_30036999","title":"The Role of the Arginine in the Conserved N-Terminal Domain RLFDQxFG Motif of Human Small Heat Shock Proteins HspB1, HspB4, HspB5, HspB6, and HspB8.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30036999","citation_count":25,"is_preprint":false},{"pmid":"27507241","id":"PMC_27507241","title":"CpG site methylation in CRYAA promoter affect transcription factor Sp1 binding in human lens epithelial cells.","date":"2016","source":"BMC ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/27507241","citation_count":20,"is_preprint":false},{"pmid":"24074001","id":"PMC_24074001","title":"A R54L mutation of CRYAA associated with autosomal dominant nuclear cataracts in a Chinese family.","date":"2013","source":"Current eye research","url":"https://pubmed.ncbi.nlm.nih.gov/24074001","citation_count":20,"is_preprint":false},{"pmid":"18803847","id":"PMC_18803847","title":"Transcriptional regulation of mouse alpha A-crystallin gene in a 148kb Cryaa BAC and its derivates.","date":"2008","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18803847","citation_count":17,"is_preprint":false},{"pmid":"30340470","id":"PMC_30340470","title":"A novel mutation in the CRYAA gene associated with congenital cataract and microphthalmia in a Chinese family.","date":"2018","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30340470","citation_count":16,"is_preprint":false},{"pmid":"23288997","id":"PMC_23288997","title":"A novel mutation in CRYAA is associated with autosomal dominant suture cataracts in a Chinese family.","date":"2012","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/23288997","citation_count":16,"is_preprint":false},{"pmid":"20465443","id":"PMC_20465443","title":"Autosomal dominant congenital nuclear cataracts caused by a CRYAA gene mutation.","date":"2010","source":"Current eye research","url":"https://pubmed.ncbi.nlm.nih.gov/20465443","citation_count":15,"is_preprint":false},{"pmid":"34071438","id":"PMC_34071438","title":"HspB4/αA-Crystallin Modulates Neuroinflammation in the Retina via the Stress-Specific Inflammatory Pathways.","date":"2021","source":"Journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34071438","citation_count":14,"is_preprint":false},{"pmid":"25729975","id":"PMC_25729975","title":"A novel 3-base pair deletion of the CRYAA gene identified in a large Chinese pedigree featuring autosomal dominant congenital perinuclear cataract.","date":"2015","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/25729975","citation_count":13,"is_preprint":false},{"pmid":"33929105","id":"PMC_33929105","title":"Cataract-causing allele in CRYAA (Y118D) proceeds through endoplasmic reticulum stress in mouse model.","date":"2021","source":"Zoological research","url":"https://pubmed.ncbi.nlm.nih.gov/33929105","citation_count":11,"is_preprint":false},{"pmid":"32791987","id":"PMC_32791987","title":"Expanding the phenotype of CRYAA nucleotide variants to a complex presentation of anterior segment dysgenesis.","date":"2020","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/32791987","citation_count":11,"is_preprint":false},{"pmid":"28640093","id":"PMC_28640093","title":"Correlations of single nucleotide polymorphisms of CRYAA and CRYAB genes with the risk and clinicopathological features of children suffering from congenital cataract.","date":"2017","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28640093","citation_count":8,"is_preprint":false},{"pmid":"37253645","id":"PMC_37253645","title":"Expression of αA-crystallin (CRYAA) in vivo and in vitro models of age-related cataract and the effect of its silencing on HLEB3 cells.","date":"2023","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/37253645","citation_count":6,"is_preprint":false},{"pmid":"22065922","id":"PMC_22065922","title":"Congenital anterior polar cataract associated with a missense mutation in the human alpha crystallin gene CRYAA.","date":"2011","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/22065922","citation_count":6,"is_preprint":false},{"pmid":"2369847","id":"PMC_2369847","title":"Regional assignment of the mouse alpha A2-crystallin gene (Crya-1) to chromosome 17A3----B by in situ hybridization.","date":"1990","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/2369847","citation_count":6,"is_preprint":false},{"pmid":"39311341","id":"PMC_39311341","title":"HSPB4/CRYAA Protect Photoreceptors during Retinal Detachment in Part through FAIM2 Regulation.","date":"2024","source":"Neurology international","url":"https://pubmed.ncbi.nlm.nih.gov/39311341","citation_count":4,"is_preprint":false},{"pmid":"40350053","id":"PMC_40350053","title":"CRYAA activates the SIRT1-pi3K/AKT signaling pathway by suppressing mir-155-5p to protect the RPE.","date":"2025","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/40350053","citation_count":3,"is_preprint":false},{"pmid":"36982926","id":"PMC_36982926","title":"Dioleoylphosphatidylglycerol Inhibits Heat Shock Protein B4 (HSPB4)-Induced Inflammatory Pathways In Vitro.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36982926","citation_count":3,"is_preprint":false},{"pmid":"1974046","id":"PMC_1974046","title":"PvuII and XhoI/EcoRV polymorphisms adjacent to the alpha A-crystallin (CRYA1) gene on human chromosome 21.","date":"1990","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/1974046","citation_count":3,"is_preprint":false},{"pmid":"39682748","id":"PMC_39682748","title":"Novel mTORC2/HSPB4 Interaction: Role and Regulation of HSPB4 T148 Phosphorylation.","date":"2024","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/39682748","citation_count":2,"is_preprint":false},{"pmid":"35531184","id":"PMC_35531184","title":"Association of single nucleotide polymorphism variations in CRYAA and CRYAB genes with congenital cataract in Pakistani population.","date":"2022","source":"Saudi journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35531184","citation_count":2,"is_preprint":false},{"pmid":"36915480","id":"PMC_36915480","title":"CRYAA and GJA8 promote visual development after whisker tactile deprivation.","date":"2023","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/36915480","citation_count":1,"is_preprint":false},{"pmid":"34010109","id":"PMC_34010109","title":"Polymorphisms in CRYAA Promoter with Susceptibility to Cataract: A Meta-Analysis.","date":"2021","source":"Seminars in ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/34010109","citation_count":1,"is_preprint":false},{"pmid":"21612679","id":"PMC_21612679","title":"[CRYAA gene mutation study in a family with autosomal dominant congenital cataract combined with microcornea].","date":"2011","source":"[Zhonghua yan ke za zhi] Chinese journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/21612679","citation_count":1,"is_preprint":false},{"pmid":"37807341","id":"PMC_37807341","title":"Mutational analysis of CRYAA gene of cataract and investigating risk assessment factors responsible for eye diseases in district buner, KPK, Pakistan.","date":"2023","source":"Cellular and molecular biology (Noisy-le-Grand, France)","url":"https://pubmed.ncbi.nlm.nih.gov/37807341","citation_count":0,"is_preprint":false},{"pmid":"38187316","id":"PMC_38187316","title":"The E156K mutation in the CRYAA gene affects the epithelial-mesenchymal transition and migration of human lens epithelial cells.","date":"2023","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/38187316","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":23505,"output_tokens":4187,"usd":0.06666,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":12080,"output_tokens":4901,"usd":0.091463,"stage2_stop_reason":"end_turn"},"total_usd":0.158123,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"A missense mutation R116C in CRYAA (alphaA-crystallin) is associated with autosomal dominant congenital cataract, establishing CRYAA as a causative gene for hereditary lens opacity.\",\n      \"method\": \"Linkage analysis and gene sequencing in an ADCC family\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic mapping plus sequencing, replicated across multiple subsequent families, but no in vitro functional assay in this paper\",\n      \"pmids\": [\"9467006\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The R116H mutation in alphaA-crystallin increases hydrophobicity of the protein, abolishes chaperone activity in a DTT-induced insulin aggregation assay, and increases binding affinity to lysozyme, indicating loss of normal chaperone function as the molecular basis for cataract formation.\",\n      \"method\": \"Recombinant protein expression in E. coli, RP-HPLC (hydrophobicity), FPLC (binding affinity), in vitro chaperone activity assay (insulin aggregation)\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal in vitro assays (chaperone activity, hydrophobicity, binding affinity) in a single rigorous study on purified recombinant protein\",\n      \"pmids\": [\"18407550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CRYAA released from injured keratocytes acts as a DAMP and activates resident macrophages via the TLR2/NF-κB signaling pathway, triggering Phase II sterile corneal inflammation responsible for vision-threatening opacity. This was suppressed in HSPB4-knockout or TLR2-knockout mice, and by anti-HSPB4 antibodies.\",\n      \"method\": \"Mouse knockout models (HSPB4-/-, TLR2-/-), antibody inhibition, temporal kinetic analysis of neutrophil infiltration, NF-κB pathway analysis\",\n      \"journal\": \"EMBO molecular medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal genetic and pharmacological approaches (two KO lines, antibody blockade, pathway analysis) in a single study, clearly establishing mechanism\",\n      \"pmids\": [\"22359280\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CRYAA expression is epigenetically repressed in age-related nuclear cataract lens epithelia via CpG island hypermethylation of the CRYAA promoter; treatment with the demethylating agent zebularine restores CRYAA mRNA and protein expression.\",\n      \"method\": \"Bisulfite genomic sequencing, RT-PCR, Western blot, demethylating agent treatment (zebularine)\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bisulfite sequencing plus functional rescue with demethylating agent, single lab but two orthogonal methods\",\n      \"pmids\": [\"22889833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Methylation of CpG sites in the CRYAA promoter directly reduces binding of transcription factor Sp1, providing the mechanistic link between promoter hypermethylation and transcriptional silencing of CRYAA.\",\n      \"method\": \"Electrophoretic mobility shift assay (EMSA) with methylated vs. unmethylated probes, demethylating agent treatment with qRT-PCR\",\n      \"journal\": \"BMC ophthalmology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA directly demonstrates reduced Sp1 binding upon methylation, supported by functional restoration data, single lab\",\n      \"pmids\": [\"27507241\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"HspB4 (CRYAA) forms hetero-complexes with HspB5 (alphaB-crystallin), and subunit exchange kinetics between HspB4 and HspB5 are slower than between HspB1 and HspB5. HspB4-HspB5 hetero-complexes exhibit distinct chaperone-like activity and structural properties compared to either homo-oligomer, suggesting that hetero-complex formation expands functional range.\",\n      \"method\": \"Biochemical and biophysical characterization (size exclusion chromatography, small-angle X-ray scattering), subunit exchange kinetics, in vitro chaperone activity assays\",\n      \"journal\": \"Biochimie\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple biophysical and biochemical methods in vitro, single lab\",\n      \"pmids\": [\"22210387\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Substitution of the conserved Arg in the N-terminal RLFDQxFG motif of HspB4 (R12 equivalent region) induces only minor changes in thermal stability and oligomeric structure compared to the larger effects seen in HspB1 and HspB8, indicating that this motif plays a distinct, context-dependent structural role in HspB4.\",\n      \"method\": \"Biophysical characterization (thermal stability, intrinsic fluorescence, size exclusion chromatography) of recombinant Arg-to-Ala mutant proteins\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro mutagenesis with multiple biophysical readouts, single lab\",\n      \"pmids\": [\"30036999\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HspB4/αA-crystallin phosphorylation at T148 regulates its anti-inflammatory function in retinal Müller glial cells: phosphomimetic T148D mutant significantly reduced expression of pro-inflammatory cytokines (IL-6, IL-1β, MCP-1, IL-18), suppressed NLRP3 inflammasome components, and nearly abolished NF-κB induction, whereas non-phosphorylatable T148A mutant was ineffective.\",\n      \"method\": \"Primary Müller glial cells from HSPB4 knockout mice, transfection with WT/T148D/T148A plasmids, qPCR for inflammatory markers, Western blot for NF-κB and NLRP3 subcellular localization\",\n      \"journal\": \"Journal of clinical medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phosphorylation-specific mutants in primary cells with multiple inflammatory readouts, single lab\",\n      \"pmids\": [\"34071438\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"αA-crystallin (HSPB4) interacts with the neuroprotective protein FAIM2, and this interaction requires phosphorylation of αA-crystallin at T148. During retinal detachment, FAIM2 is induced and co-immunoprecipitates with αA-crystallin, and αA-crystallin stabilizes FAIM2 to promote photoreceptor survival.\",\n      \"method\": \"Co-immunoprecipitation, immunohistochemistry, immunoblotting, TUNEL staining, cell culture model with FasL-induced photoreceptor death, phosphomimetic/non-phosphorylatable mutants\",\n      \"journal\": \"Neurology international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP plus functional cell viability data and in vivo retinal detachment model, single lab\",\n      \"pmids\": [\"39311341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"mTORC2 is identified as a kinase that phosphorylates HSPB4 at T148 in vitro; additionally, the chaperone function of HSPB4 further strengthens the interaction with mTORC2, suggesting a multi-faceted regulatory relationship.\",\n      \"method\": \"In vitro kinome profiling, bioinformatics analysis, chemoproteomics, in vitro kinase assay\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay plus chemoproteomics for interaction, single lab, T148 phosphorylation confirmed in vitro\",\n      \"pmids\": [\"39682748\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The R12L mutation in CRYAA causes aggregation of the mutant protein in the insoluble fraction, forms large cytoplasmic aggregates and aggresomes in HeLa cells, and increases overall CRYAA protein expression levels, suggesting that mutation-induced aggregation underlies cataract pathogenesis.\",\n      \"method\": \"Transfection of WT and R12L-CRYAA in HEK293T and HeLa cells, Western blotting (solubility), immunofluorescence (aggresome formation)\",\n      \"journal\": \"BMC medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two orthogonal methods (solubility fractionation and immunofluorescence) in two cell lines, single lab\",\n      \"pmids\": [\"30340470\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"In a CRYAA Y118D mutant mouse model, cataract formation is associated with activation of the endoplasmic reticulum stress-unfolded protein response (ERS-UPR) pathway, with up-regulated ERS-UPR genes; prolonged UPR activation leads to proteotoxic cell death in lens fibers.\",\n      \"method\": \"Knock-in mouse model, histological analysis, transcriptome analysis, key pathway analysis\",\n      \"journal\": \"Zoological research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo mouse model with transcriptomic pathway analysis, single lab\",\n      \"pmids\": [\"33929105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Silencing of CRYAA in HLEB3 lens epithelial cells increases apoptosis and autophagy, demonstrating that CRYAA is required to suppress apoptotic and autophagic pathways in lens epithelial cell homeostasis.\",\n      \"method\": \"siRNA knockdown, Western blotting for apoptosis and autophagy markers, flow cytometry, CCK-8 viability assay\",\n      \"journal\": \"Aging\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single knockdown approach with limited pathway resolution in abstract\",\n      \"pmids\": [\"37253645\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CRYAA overexpression in RPE cells reduces miR-155-5p levels, which in turn de-represses SIRT1 (confirmed by dual luciferase assay showing miR-155-5p binds SIRT1 3'-UTR), leading to activation of the PI3K/AKT signaling pathway and protection from H2O2-induced apoptosis.\",\n      \"method\": \"Stable overexpression in ARPE-19 cells, RT-qPCR, dual luciferase reporter assay, Western blotting for PI3K/AKT pathway, flow cytometry for apoptosis, in vivo mouse retinal degeneration model with AAV-Cryaa injection\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — luciferase reporter confirms miR-155-5p/SIRT1 binding site, pathway confirmed by SIRT1 silencing rescue experiment and in vivo AAV model, single lab\",\n      \"pmids\": [\"40350053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The E156K mutation in CRYAA induces epithelial-mesenchymal transition (EMT) in human lens epithelial cells, increasing mesenchymal markers (N-cadherin, vimentin) and decreasing epithelial marker (E-cadherin), with enhanced cell migration via activation of FAK/Src and Wnt/β-catenin signaling pathways.\",\n      \"method\": \"Knockdown and replacement with WT or E156K-mutant CRYAA in HLECs, Western blotting for EMT markers, rhodamine cytoskeleton staining, migration assay, β-catenin inhibitor (ICG001) and FAK/Src inhibitor treatments\",\n      \"journal\": \"Heliyon\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (morphology, protein markers, functional migration assay, pharmacological inhibition), single lab\",\n      \"pmids\": [\"38187316\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"A 148 kb BAC transgene containing the Cryaa locus recapitulates endogenous alphaA-crystallin expression pattern in the lens. Deletion of the distal control region DCR3 from either the BAC or a 15 kb Cryaa fragment shows that DCR3 functions as a distal enhancer active during late primary lens fiber cell differentiation.\",\n      \"method\": \"BAC transgenic mice, standard transgenic mice, EGFP reporter, temporal/spatial expression analysis by fluorescence imaging\",\n      \"journal\": \"BMC developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — BAC transgenic approach with deletion of regulatory region and comparison to endogenous expression, single lab\",\n      \"pmids\": [\"18803847\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HSPB4 (CRYAA) activates TLR2 signaling in corneal cells acting as a DAMP; dioleoylphosphatidylglycerol (DOPG) inhibits TLR2 activation induced by HSPB4 in vitro, and this TLR2 activation requires the co-receptor CD14.\",\n      \"method\": \"In vitro TLR2 activation assay, CD14 co-receptor requirement established by knockdown/inhibition\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single in vitro assay, single lab, CD14 requirement inferred from inhibition experiments described briefly in abstract\",\n      \"pmids\": [\"36982926\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CRYAA (alphaA-crystallin/HspB4) functions as a lens-predominant molecular chaperone that prevents aggregation of β/γ-crystallins to maintain lens transparency; disease-causing mutations (e.g., R116C/H, R12C/L, R54C) reduce chaperone activity, increase hydrophobicity, and/or promote protein aggregation/aggresome formation, causing congenital cataract; outside the lens, CRYAA acts as a DAMP released from injured cells to activate macrophages via a TLR2/NF-κB axis driving sterile corneal inflammation, and in retinal cells its phosphorylation at T148 by mTORC2 regulates anti-inflammatory (NLRP3/NF-κB suppression), anti-apoptotic, and neuroprotective functions including stabilization of FAIM2; CRYAA transcription is regulated by Sp1 binding to its promoter, which is silenced by CpG methylation in age-related cataract.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CRYAA (alphaA-crystallin/HspB4) is a lens-predominant small heat-shock protein whose core function is molecular chaperone activity that prevents protein aggregation to maintain lens transparency, with additional context-dependent cytoprotective and immunomodulatory roles in cornea and retina [#1, #2]. Within the lens it suppresses substrate aggregation, and the disease-causing R116H substitution increases protein hydrophobicity, raises lysozyme-binding affinity, and abolishes chaperone activity, defining loss of chaperone function as one molecular route to cataract [#1]. CRYAA participates in mixed oligomers, forming hetero-complexes with HspB5/alphaB-crystallin that display distinct chaperone-like activity and slower subunit exchange than other small-HSP pairs [#5]. Multiple dominant cataract mutations act through gain-of-toxicity mechanisms rather than simple loss of chaperoning: R12L drives accumulation of insoluble protein and cytoplasmic aggresomes [#10], Y118D triggers ER-stress/unfolded-protein-response activation and proteotoxic death in lens fibers [#11], and E156K induces epithelial-mesenchymal transition in lens epithelial cells via FAK/Src and Wnt/beta-catenin signaling [#14]. CRYAA itself is required for lens epithelial homeostasis, restraining apoptosis and autophagy [#12], and its expression is silenced in age-related cataract by CpG hypermethylation of its promoter, which reduces Sp1 binding and transcription [#3, #4]. Outside the lens, CRYAA released from injured keratocytes functions as a DAMP that activates resident macrophages through a TLR2/NF-kappaB axis to drive sterile corneal inflammation [#2]. In the retina, mTORC2-mediated phosphorylation of CRYAA at T148 confers anti-inflammatory, anti-apoptotic, and neuroprotective activity, including suppression of NLRP3/NF-kappaB signaling [#7, #9] and phosphorylation-dependent binding and stabilization of the pro-survival factor FAIM2 to protect photoreceptors [#8]. The R116C mutation in CRYAA causes autosomal dominant congenital cataract [#0].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established CRYAA as a disease gene by linking a specific missense mutation to inherited lens opacity, answering whether crystallin genes themselves cause cataract.\",\n      \"evidence\": \"Linkage analysis and gene sequencing in an autosomal dominant congenital cataract family\",\n      \"pmids\": [\"9467006\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No in vitro functional assay to show how R116C alters protein behavior\", \"Did not distinguish loss-of-function from gain-of-toxicity\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Resolved the molecular basis of mutation-driven cataract by showing the disease substitution abolishes chaperone activity and increases hydrophobicity, defining a loss-of-chaperone mechanism.\",\n      \"evidence\": \"Recombinant R116H protein with RP-HPLC, FPLC binding, and insulin-aggregation chaperone assays\",\n      \"pmids\": [\"18407550\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vitro assays do not establish in vivo lens consequences\", \"Tested R116H rather than the original R116C allele\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified the genomic regulatory element controlling lens-specific CRYAA expression, addressing how the gene is restricted to differentiating fiber cells.\",\n      \"evidence\": \"BAC transgenic mice with EGFP reporter and deletion of the DCR3 distal enhancer\",\n      \"pmids\": [\"18803847\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Trans-acting factors binding DCR3 not identified\", \"Single transgenic system\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined CRYAA's oligomeric biology by showing it forms hetero-complexes with HspB5 with distinct properties, refining what the functional chaperone species actually is.\",\n      \"evidence\": \"SEC, SAXS, subunit-exchange kinetics, and in vitro chaperone assays of HspB4/HspB5 complexes\",\n      \"pmids\": [\"22210387\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance of hetero-complex stoichiometry not established\", \"Single lab biophysical study\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Revealed an unexpected extracellular, pro-inflammatory role by showing released CRYAA acts as a DAMP driving sterile corneal inflammation through TLR2/NF-kappaB.\",\n      \"evidence\": \"HSPB4-/- and TLR2-/- mice, anti-HSPB4 antibody blockade, and NF-kappaB pathway analysis\",\n      \"pmids\": [\"22359280\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct CRYAA-TLR2 binding not structurally defined\", \"Receptor co-factors not yet mapped\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Explained age-related loss of CRYAA expression by demonstrating promoter CpG hypermethylation represses transcription and is reversible by demethylation.\",\n      \"evidence\": \"Bisulfite sequencing, RT-PCR, Western blot, and zebularine rescue in cataract lens epithelia\",\n      \"pmids\": [\"22889833\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not identify the transcription factor affected by methylation\", \"Correlative human-tissue data\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Provided the mechanistic link for methylation-driven silencing by showing methylated CpG sites reduce Sp1 binding to the CRYAA promoter.\",\n      \"evidence\": \"EMSA with methylated vs unmethylated probes plus demethylation/qRT-PCR\",\n      \"pmids\": [\"27507241\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Other transcription factors at the promoter not excluded\", \"Single-lab EMSA evidence\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showed that not all cataract mutations act by loss of chaperoning, identifying R12L as a gain-of-toxicity allele that drives insoluble aggregation and aggresome formation.\",\n      \"evidence\": \"Transfection of WT/R12L in HEK293T and HeLa cells with solubility fractionation and immunofluorescence\",\n      \"pmids\": [\"30340470\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Aggregation shown in non-lens cell lines\", \"Chaperone activity of R12L not directly measured\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Tested the structural role of the conserved N-terminal Arg motif, showing CRYAA differs from other small HSPs and that this residue has a context-dependent role.\",\n      \"evidence\": \"Biophysical characterization of Arg-to-Ala mutants (thermal stability, fluorescence, SEC)\",\n      \"pmids\": [\"30036999\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not connect motif perturbation to disease phenotype\", \"Single-lab biophysics\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established a phosphorylation switch by showing T148 phosphorylation governs CRYAA's anti-inflammatory activity in retinal Muller glia.\",\n      \"evidence\": \"Phosphomimetic T148D vs T148A in primary HSPB4-knockout Muller cells with inflammatory marker qPCR and NF-kappaB/NLRP3 readouts\",\n      \"pmids\": [\"34071438\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The responsible kinase was not yet identified\", \"Single cell-type model\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Connected a cataract mutation to a proteostasis stress pathway in vivo, showing Y118D activates ER-stress/UPR leading to proteotoxic fiber cell death.\",\n      \"evidence\": \"Y118D knock-in mouse with histology and transcriptome pathway analysis\",\n      \"pmids\": [\"33929105\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal versus consequential role of UPR not separated\", \"Single mutant allele studied\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstrated CRYAA is required for lens epithelial homeostasis by showing its loss elevates apoptosis and autophagy.\",\n      \"evidence\": \"siRNA knockdown in HLEB3 cells with apoptosis/autophagy markers, flow cytometry, and viability assay\",\n      \"pmids\": [\"37253645\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single knockdown approach with limited pathway resolution\", \"No rescue control reported\", \"Mechanism linking CRYAA to autophagy unresolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified a non-chaperone disease mechanism by which the E156K mutation drives EMT in lens epithelium through FAK/Src and Wnt/beta-catenin signaling.\",\n      \"evidence\": \"Knockdown-replacement of WT vs E156K in HLECs with EMT markers, migration assays, and pathway inhibitors\",\n      \"pmids\": [\"38187316\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How E156K engages FAK/Src or Wnt is not defined\", \"Single-lab cell model\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Refined the corneal DAMP mechanism by establishing CD14 as a required co-receptor for CRYAA-driven TLR2 activation and identifying DOPG as an inhibitor.\",\n      \"evidence\": \"In vitro TLR2 activation assay with CD14 knockdown/inhibition and DOPG treatment\",\n      \"pmids\": [\"36982926\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single in vitro assay with CD14 requirement inferred from inhibition\", \"Not confirmed in vivo\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified the kinase for the T148 phosphoswitch, showing mTORC2 phosphorylates CRYAA in vitro and that chaperone function reinforces the interaction.\",\n      \"evidence\": \"In vitro kinome profiling, chemoproteomics, and in vitro kinase assay\",\n      \"pmids\": [\"39682748\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"T148 phosphorylation by mTORC2 confirmed only in vitro\", \"Cellular and in vivo regulation not yet validated\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Linked the T148 phosphoswitch to a concrete neuroprotective output by showing phospho-dependent binding and stabilization of FAIM2 to promote photoreceptor survival.\",\n      \"evidence\": \"Reciprocal Co-IP, retinal detachment model, TUNEL, and phosphomimetic mutants in FasL-induced photoreceptor death\",\n      \"pmids\": [\"39311341\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which CRYAA stabilizes FAIM2 not resolved\", \"Single-lab model\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defined a cytoprotective signaling axis in retinal pigment epithelium whereby CRYAA lowers miR-155-5p to de-repress SIRT1 and activate PI3K/AKT against oxidative apoptosis.\",\n      \"evidence\": \"ARPE-19 overexpression, dual-luciferase miR-155-5p/SIRT1 binding, pathway Western blots, SIRT1-silencing rescue, and AAV-Cryaa in vivo model\",\n      \"pmids\": [\"40350053\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How CRYAA regulates miR-155-5p levels is unknown\", \"Single-lab study\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How CRYAA's intracellular chaperone activity, its phosphorylation-dependent signaling roles, and its extracellular DAMP function are integrated within a single tissue context remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of how T148 phosphorylation alters oligomer or partner binding\", \"Relationship between hetero-complex composition and tissue-specific function unclear\", \"Whether non-chaperone disease mechanisms (aggregation, EMT, UPR) share a common upstream trigger is unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [1, 5]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [1, 5]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [2, 7]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [12, 13]}\n    ],\n    \"complexes\": [\n      \"HspB4-HspB5 (alphaA/alphaB-crystallin) hetero-oligomer\"\n    ],\n    \"partners\": [\n      \"CRYAB\",\n      \"TLR2\",\n      \"CD14\",\n      \"FAIM2\",\n      \"mTORC2\",\n      \"Sp1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":8,"faith_total":8,"faith_pct":100.0}}